Kiromic Biopharma Inc (KRBP) — Financial Flexibility Index
Kiromic Biopharma Inc (KRBP) has a Financial Flexibility Index of -0.17x as of December 2024. Free cash flow of $-3.62 Million (operating CF $-3.65 Million minus capex $28.00K) represents 0% of total liabilities ($21.13 Million). Check KRBP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kiromic Biopharma Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Kiromic Biopharma Inc across 7 annual periods. For the full cash flow conversion analysis, see Kiromic Biopharma Inc cash flow conversion.
Annual Financial Flexibility Index for Kiromic Biopharma Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Kiromic Biopharma Inc. Explore KRBP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.90x | $-19.09 Million | $-19.46 Million | $21.13 Million | ▲ +8.5% |
| 2023 | -0.99x | $-21.02 Million | $-21.23 Million | $21.29 Million | ▲ +7.2% |
| 2022 | -1.06x | $-18.87 Million | $-23.75 Million | $17.74 Million | ▲ +80.3% |
| 2021 | -5.40x | $-18.43 Million | $-20.32 Million | $3.41 Million | ▼ -69.9% |
| 2020 | -3.18x | $-4.67 Million | $-6.13 Million | $1.47 Million | ▲ +17.9% |
| 2019 | -3.88x | $-2.61 Million | $-2.91 Million | $673.70K | ▼ -17.4% |
| 2018 | -3.30x | $-2.02 Million | $-2.15 Million | $610.70K | — |